Trials / Completed
CompletedNCT01578330
A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720
A 12 -Month, Open-label, Multi-center Pilot Study to Explore the Health Outcomes of FTY720 in RRMS Patients Who Have Previously Been Treated With Other Disease Modifying Therapies (DMT)- Fine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study will assess the patients' satisfaction of treatment after 12 months treatment with fingolimod It also will assess the tolerability profile of fingolimod in a small population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fingolimod | Fingolimod 0.5mg orally once a day without food. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2012-04-16
- Last updated
- 2016-06-07
- Results posted
- 2016-06-07
Locations
11 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01578330. Inclusion in this directory is not an endorsement.